DuPont de Nemours, Inc.

As of October 17, 2025, DuPont de Nemours, Inc. is considered an attractive investment due to its competitive P/E ratio of 21, a high dividend yield of 188.98%, and potential for recovery despite recent underperformance against the S&P 500.

As of October 17, 2025, DuPont de Nemours, Inc. is considered an attractive investment due to its undervalued metrics, including a P/E ratio of 21 and an EV to EBITDA of 10.75, despite a challenging year, indicating better value compared to peers.

As of October 17, 2025, DuPont de Nemours, Inc. is considered undervalued with a favorable valuation grade shift, reflected by a P/E ratio of 21 and a stock return of 49.51% over the last three years, despite underperforming the S&P 500's 81.19% return.

DuPont de Nemours, Inc. reported strong financial results for the quarter ending June 2025, with record net sales of USD 3,257 million and a net profit of USD 369.33 million. The company also achieved a high dividend per share of USD 5.2 and improved its interest coverage ratio, reflecting solid operational efficiency and commitment to shareholder value.

As of October 3, 2025, DuPont de Nemours, Inc. shows a bullish technical trend with positive momentum indicators, having outperformed the S&P 500 in the past week but underperformed year-to-date.

As of October 3, 2025, DuPont de Nemours, Inc. shows a bullish technical trend with strong weekly indicators and positive daily moving averages, despite mixed signals from the MACD and underperformance in the long term compared to the S&P 500.

As of October 3, 2025, DuPont de Nemours, Inc. shows a bullish technical trend with positive momentum indicators, despite mixed signals from the monthly KST, and has outperformed the S&P 500 in the short term but underperformed year-to-date.

As of September 12, 2025, DuPont de Nemours, Inc. shows a mildly bullish trend, supported by a bullish weekly MACD and Bollinger Bands, despite mixed signals from other indicators.

As of August 7, 2025, DuPont de Nemours, Inc. is considered undervalued with a valuation grade of attractive, supported by competitive financial ratios despite recent stock performance lagging behind the S&P 500.

As of May 2, 2025, DuPont de Nemours, Inc. is fairly valued with a P/E ratio of 21 and an EV to EBITDA of 10.75, aligning with industry standards, despite a year-to-date stock performance lagging at -12.13% compared to the S&P 500's 2.44%.

As of June 3, 2025, DuPont de Nemours, Inc. shows a mildly bearish trend, with daily moving averages and weekly Bollinger Bands indicating bearish sentiment, while mixed signals from MACD and RSI suggest uncertainty in the short term.

As of March 2022, the management team of DuPont de Nemours, Inc. includes Executive Chairman and CEO Edward Breen, Lead Independent Director Alexander Cutler, and Independent Directors Amy Brady, Ruby Chandy, Franklin Clyburn, and Terrence Curtin. They are responsible for the company's strategic direction and governance.

DuPont de Nemours, Inc. operates in the Chemicals & Petrochemicals industry, providing technology-based materials and solutions. As of March 2025, it reported net sales of $3.066 billion and a net loss of $548 million, with a market cap of $28.1 billion.

As of Jun 18, DuPont de Nemours, Inc. has a market capitalization of $28.1 billion, with recent net sales of $12.5 billion and a net profit of $47 million.